Similar Search Results

Compulsory licensing and access to drugs

Stavropoulou, Charitini; Valletti, Tommaso M. - In: The European journal of health economics : HEPAC ; … 16 (2015) 1, pp. 83-94

Persistent link: https://www.econbiz.de/10011300285

Ausrichtung von Forschung und Entwicklung in der Pharmaindustrie : keine Chance für seltene und Dritte-Welt-Erkrankungen?

Marckmann, Georg - In: Bittere Arznei : Wirtschaftsethik und Ökonomik der …, (pp. 71-82). 2008

Persistent link: https://www.econbiz.de/10003624109

Big pharma and monopoly capitalism: a long-term view

Dosi, Giovanni; Marengo, Luigi; Staccioli, Jacopo; … - 2021

an innovation rewarding institution. According to our analysis, pharma patents have constituted legal barriers to protect …

Persistent link: https://www.econbiz.de/10012604733

Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978-2002

Qian, Yi - 2014

-effects regressions, this study yields robust results. National patent protection alone does not stimulate domestic innovation, as …, domestic innovation accelerates in countries with higher levels of economic development, educational attainment, and economic …

Persistent link: https://www.econbiz.de/10012751759

Productivity and heterogeneous knowledge : exploring the relationship in a sample of drug developers

Bottazzi, Giulio; Plotnikova, Tatiana - 2010

This paper aims to investigate the effect of knowledge characteristics on the total factor productivity of firms developing drugs in the pharmaceutical industry. We decompose knowledge into knowledge associated with the technological firm portfolio and knowledge related to R&D projects, which...

Persistent link: https://www.econbiz.de/10003989032

How does basic research improve innovation performance in the world's major pharmaceutical firms?

Leten, Bart; Kelchtermans, Stijn; Belderbos, René - In: Industry and innovation 29 (2022) 3, pp. 396-424

Persistent link: https://www.econbiz.de/10013170079

COVID-19 vaccines and the role of patents

Larson, Kelli - In: International journal of intellectual property … 11 (2021) 4, pp. 486-491

Persistent link: https://www.econbiz.de/10012800211

Accelerating vaccine innovation for emerging infectious diseases via parallel discovery

Barberio, Joseph; Becraft, Jacob; Ben Chaouch, Zied; … - In: Entrepreneurship and innovation policy and the economy … 2 (2023), pp. 9-39

Persistent link: https://www.econbiz.de/10015049952

A cross-country index of intellectual property rights in pharmaceutical inventions

Liu, Ming; La Croix, Sumner J. - In: Research policy : policy, management and economic … 44 (2015) 1, pp. 206-216

Persistent link: https://www.econbiz.de/10011317950

Big Pharma, little science? : a bibliometric perspective on Big Pharma's R&D decline

Rafols, Ismael; Hopkins, Michael M.; Hoekman, Jarno; … - In: Technological forecasting & social change : an … 81 (2014), pp. 22-38

Persistent link: https://www.econbiz.de/10010403289

1
2
3
4
5
6
7
8
9
10
Next
Last